Thoracic aortic aneurysm future or investigational therapies
Thoracic aortic aneurysm Microchapters |
Differentiating Thoracic Aortic Aneurysm from other Diseases |
---|
Diagnosis |
Treatment |
Special Scenarios |
Case Studies |
Thoracic aortic aneurysm future or investigational therapies On the Web |
FDA on Thoracic aortic aneurysm future or investigational therapies |
CDC on Thoracic aortic aneurysm future or investigational therapies |
Thoracic aortic aneurysm future or investigational therapies in the news |
Blogs on Thoracic aortic aneurysm future or investigational therapies |
Directions to Hospitals Treating Thoracic aortic aneurysm future or investigational therapies |
Risk calculators and risk factors for Thoracic aortic aneurysm future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Future or investigational therapies
Recent advances in thoracic aortic aneurysm treatment:
- The use of endovascular stent grafting, which is a less invasive alternative to open surgery, for the treatment of descending thoracic and thoracoabdominal aneurysms.
- Open-surgical versus endovascular stenting showed a decrease of operative mortality and a decrease in the occurrence of paraplegia, blood loss, length of ICU stay, and operative time.
- Even though late survival rates are equivalent between open surgical repair and endovascular repair, the early operative mortality rates of endovascular repair are lower
- The advances in aortic substitutes, cerebral protection, and perioperative care have led to improved results